Skip to main content

Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · IEX Real-Time Price · USD
3.55 0.05 (1.43%)
Oct 26, 2021 11:35 AM EDT - Market open
Market Cap83.97M
Revenue (ttm)14.54M
Net Income (ttm)n/a
Shares Out20.74M
EPS (ttm)-1.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,623
Open3.56
Previous Close3.50
Day's Range3.50 - 3.62
52-Week Range2.61 - 14.41
Betan/a
AnalystsBuy
Price Target11.00 (+209.9%)
Earnings Daten/a

About VVOS

Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing, such as mild-to-moderate obstructive sleep apnea (OSA). Its treatment, the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of mild to moderate OSA. Vivos Therapeutics also offers VivoScore, a comprehensive home sleep apnea test. The company markets and sells its Vivos System to licensed professionals...

IndustryMedical Devices
IPO DateDec 11, 2020
Employees133
Stock ExchangeNASDAQ
Ticker SymbolVVOS
Full Company Profile

Financial Performance

In 2020, VVOS's revenue was $13.07 million, an increase of 14.68% compared to the previous year's $11.39 million. Losses were -$12.06 million, 12.1% more than in 2019.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for VVOS stock is "Buy." The 12-month stock price forecast is 11.00, which is an increase of 209.86% from the latest price.

Price Target
$11.00
(209.86% upside)
Analyst Consensus: Buy

News

Vivos Therapeutics Announces 2021 Annual Breathing Wellness Conference Presented by The Vivos Institute

Dentists from around the world to learn about the innovative and life-changing treatments for patients suffering from obstructive sleep apnea and snoring Dentists from around the world to learn about th...

6 days ago - GlobeNewsWire

Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic...

HIGHLANDS RANCH, Colo., Oct. 19, 2021 /PRNewswire/ -- Vivos Therapeutics, Inc. ("Vivos" or "the Company") (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovativ...

1 week ago - PRNewsWire

Children in Latest Clinical Study Show Significant Reduction of Tooth Decay After Treatment with Vivos Guides

HIGHLANDS RANCH, Colo., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing inno...

1 week ago - GlobeNewsWire

Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company's Technology for Obstructive ...

Drs. Clete Kushida of Stanford and Cecilia Wu of University of Alberta to lead a team of prominent, multi-disciplinary medical doctors guiding research and fostering increased physician-dental collabora...

1 month ago - GlobeNewsWire

Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

Vivos management to present at 7:00 am EDT on September 13, 2021

1 month ago - GlobeNewsWire

Implied Volatility Surging for Vivos (VVOS) Stock Options

Investors need to pay close attention to Vivos (VVOS) stock based on the movements in the options market lately.

2 months ago - Zacks Investment Research

Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstruct...

HIGHLANDS RANCH, Colo., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing inno...

2 months ago - GlobeNewsWire

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered brea...

2 months ago - Benzinga

VVOS Stock: The Sleep Apnea Device News That Is Waking Up Vivos Therapeutics Shares

Vivos Therapeutics (VVOS) stock is taking off on Monday morning after revealing clearance from the FDA for its sleep apnea device. The post VVOS Stock: The Sleep Apnea Device News That Is Waking Up Vivo...

2 months ago - InvestorPlace

Why Vivos Therapeutics Shares Are Soaring Today

Vivos Therapeutics (NASDAQ: VVOS) is surging higher today after the company announced the U.S. Food and Drug Administration granted 510(k) market clearance to its mmRNA device for treating mild to moder...

2 months ago - Benzinga

Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device

The FDA has granted 510(k) clearance to Vivos Therapeutics Inc's (NASDAQ:VVOS) mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device. The device is indicated...

2 months ago - Benzinga

FDA Grants 510(k) Market Clearance to Vivos Therapeutics' mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea

Part of the Vivos System Treatment, the mmRNA Device Represents a Highly Effective Non-Surgical, Non-Invasive and Non-Pharmaceutical Alternative for Patients Suffering from OSA

2 months ago - GlobeNewsWire

Detailed Summary of Study Reporting that One in Four Patients Show No Symptoms of Obstructive Sleep Apnea After Vivos...

HIGHLANDS RANCH, Colo., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innov...

2 months ago - GlobeNewsWire

Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update

Second Quarter Revenue Increased Over 37% Year-Over-Year and 30% Over Q1 2021

2 months ago - GlobeNewsWire

Vivos Therapeutics Opens State of the Art International Training Center In Denver

The Vivos Institute Is Expected to Significantly Increase Vivos' Ability to Educate Healthcare Providers on Ways to Help Millions of People Suffering from Sleep Apnea and its Comorbidities The Vivos Ins...

2 months ago - GlobeNewsWire

One in Four Patients in Latest Clinical Study Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment

HIGHLANDS RANCH, Colo., July 13, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing inno...

3 months ago - GlobeNewsWire

Making a List of Penny Stocks to Buy? Here's 7 to Watch in Summer 2021

Does your list of penny stocks to watch include these 7 hot small-caps? The post Making a List of Penny Stocks to Buy?

3 months ago - PennyStocks

Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update

Management to Host Conference Call Today at 5:00 pm ET Management to Host Conference Call Today at 5:00 pm ET

5 months ago - GlobeNewsWire

Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters' Option to Purcha...

HIGHLANDS RANCH, Colo., May 11, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments f...

5 months ago - GlobeNewsWire

Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering

HIGHLANDS RANCH, Colo., May 06, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments f...

5 months ago - GlobeNewsWire

Vivos Therapeutics Leads the Battle Against Obstructive Sleep Apnea (OSA)

Sleeping well plays an essential role in physical health. In fact, it is part of the recovery, healing and repair process of many body functions.

6 months ago - Benzinga

Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education

HIGHLANDS RANCH, Colo., April 14, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diag...

6 months ago - GlobeNewsWire

Vivos Therapeutics to Participate at the Emerging Growth Conference

Vivos management to present at 9:00 am EDT on April 14, 2021 Vivos management to present at 9:00 am EDT on April 14, 2021

6 months ago - GlobeNewsWire

Investing in Sleep Apnea Companies

Three stocks to have on your radar in the healthcare space.

Other symbols:INSPRMD
6 months ago - The Motley Fool